Renal Damage in the SHR/N-cp Type 2 Diabetes Model: Comparison of an Angiotensin-Converting Enzyme Inhibitor and Endothelin Receptor Blocker-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renal Damage in the SHR/N-cp Type 2 Diabetes Model: Comparison of an Angiotensin-Converting Enzyme Inhibitor and Endothelin Receptor Blocker

Published:2003-09 Issue:9 Volume:83 Page:1267-1277
ISSN:0023-6837
Container-title:Laboratory Investigation
language:
Short-container-title:Lab Invest

Author:

Gross Marie-Luise,Ritz Eberhard,Schoof Arne,Helmke Burkhard,Parkman Amy,Tulp Orien,Münter Klaus,Amann Kerstin

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference48 articles.

1. Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and βblockers

2. Cardiac remodelling in experimental renal failure - an immunohistochemical study

3. Ameliorated Glomerular Injury in Mice Overexpressing Brain Natriuretic Peptide with Renal Ablation

4. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure

5. Transforming growth factor-β as a target for treatment in diabetic nephropathy

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease;Expert Opinion on Investigational Drugs;2020-12-30

2. Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics;The American Journal of Pathology;2019-02

3. Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy;Diabetes, Obesity and Metabolism;2018-03-09

4. Endothelin A receptor antagonists in diabetic kidney disease;Current Opinion in Nephrology and Hypertension;2017-09

5. A recombinant TGF-β1 vaccine ameliorates diabetic nephropathy in OLETF rats;Immunotherapy;2016-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3